DCH36_06
Based on 1 publication(s) in Google Scholar
DCH36_06 is a potent and selective p300/CBP inhibitor with IC50s of 0.6 μM and 3.2 μM for p300 and CBP, respectively. DCH36_06 mediated p300/CBP inhibition leading to hypoacetylation on H3K18 in leukemic cells. Anti-tumor activity.
연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.
- Purity : 99.19%
- CAS No.: 593273-05-3
- 화학식: C18H13ClN2O3S
- 분자량:372.83
-
보관:
4°C, protect from light
* In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
-
용액&용해도
- 순도&문서
- References
-
Help & FAQs
-
HY-134964
CTBp300 Activator -
HY-129039
Butyrolactone 3Gcn5 Inhibitor -
HY-124696
PU139HAT Inhibitor -
HY-15887
MG 149Tip60 Inhibitor -
HY-N2020
Anacardic AcidHistone Acetyltransferase Inhibitor -
HY-107455
A-485p300/CBP Inhibitor -
HY-116673
TTK21CBP/p300 Activator -
HY-134964R
CTB (Standard)p300 Activator -
HY-124960
CTPBHistone Acetyltransferase Activator -
HY-134901
WM-3835HBO1 Inhibitor -
HY-N2345
Procyanidin B3Histone Acetyltransferase Inhibitor -
HY-102058
WM-1119KAT6A Inhibitor
Publications Citing Use of MedChemExpress (MCE) DCH36_06
More
Biological Activity
제품 설명
IC50 & Target
|
CBP/p300 |
In Vitro
DCH36_06 (6.7-20 μM; 24-48 hours) treatment arrests cell cycle at G1 phase and induces apotosis in a dose-dependent manner in leukemic cells[1].
DCH36_06 (5-10 μM; 24 hours) treatment significantly activates the cleavage of pro-caspase 3, pro-caspase 9 and PARP1 at dose-dependent manner[1].
DCH36_06 shows potent antiproliferative activity against tested leukemia cell lines (CEM, MOLT3, MOLT4, Jurkat, MV4-11, THP-1, RS4; 11, KOPN8, Kasumi-1 and K562 cells) in a dose-dependent manner with IC50 values at single-digit micromolar range[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:MV4-11 cells
-
Concentration:6.7 μM, 20 μM
-
Incubation Time:24 hours, 48 hours
-
Result:Dose-dependently arrested cell cycle at G1 phase.
-
Cell Line:MV4-11 cells
-
Concentration:6.7 μM, 20 μM
-
Incubation Time:24 hours, 48 hours
-
Result:Significantly induced apoptosis.
-
Cell Line:MV4-11 cells
-
Concentration:5 μM, 10 μM
-
Incubation Time:24 hours
-
Result:Significantly activated the cleavage of pro-caspase 3, pro-caspase 9 and PARP1 at dose-dependent manner.
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:MV4-11 xenograft nude mice[1]
-
Dosage:25 mg/kg, 50 mg/kg
-
Administration:Intraperitoneal injection; every two days; for 20 days
-
Result:The tumor growth rate showed significant reduction in dose-dependent manner.
Chemical Information
-
CAS No. 593273-05-3
-
Appearance Solid
-
분자량 372.83
-
화학식 C18H13ClN2O3S
-
Color Orange to red
-
SMILES
O=C(/C(C(N1C2=CC=C(C)C(Cl)=C2)=O)=C\C=C\C3=CC=CO3)NC1=S
-
선적
Room temperature in continental US; may vary elsewhere.
-
보관
4°C, protect from light
* In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
Publications (1)
-
Journal Impact Factor
-
Most Recent
-
Biol Trace Elem Res
Role of H3K18 Acetylation in Cadmium-Associated Modulation of the Nrf2-Keap1/NF-κB Axis and Liver Fibrosis Progression. [Abstract]2026 Jun 27. PMID: 42364051
용액&용해도
In Vitro:
DMSO : 125 mg/mL (335.27 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
In Vivo:
Select the appropriate dissolution method based on your experimental animal and administration route.
- For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
- To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for In Vivo experiments, it is recommended to prepare freshly and use it on the same day.
- The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.
Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline
Solubility: ≥ 2.08 mg/mL (5.58 mM); Clear solution
This protocol yields a clear solution of ≥ 2.08 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (20.8 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.
Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
Add each solvent one by one: 10% DMSO 90% (20% SBE-β-CD in Saline)
Solubility: 2.08 mg/mL (5.58 mM); Suspended solution; Need ultrasonic
This protocol yields a suspended solution of 2.08 mg/mL. Suspended solution can be used for oral and intraperitoneal injection.
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (20.8 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
In Vivo Dissolution Calculator
Please enter the basic information of animal experiments:
-
-
-
-
Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Please enter your animal formula composition:
-
%DMSO +
Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
-
%+
-
+%Tween-80 + +
-
%Saline +
The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
Working solution concentration: 0.22 mg/mL
Method for preparing stock solution: mg drug dissolved in μL DMSO. Stock solution concentration: mg/mL. * In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
1. Take μL DMSO stock solution;
2. Add μL .
μL , mix evenly;
3. Then add μL Tween 80, mix evenly;
4. Then add μL
Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
순도&문서
-
Data Sheet (275 KB)
-
SDS (393 KB)
- English - EN (393 KB)
- Français - FR (393 KB)
- Deutsch - DE (393 KB)
- Norwegian - NO (393 KB)
- Español - ES (393 KB)
- Swedish - SV (393 KB)
- Italian - IT (393 KB)
- Korean - KR (393 KB)
- Portuguese - PT (393 KB)
-
Handling Instructions (2659 KB)
References
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 2.6822 mL | 13.4109 mL | 26.8219 mL | 67.0547 mL |
| 5 mM | 0.5364 mL | 2.6822 mL | 5.3644 mL | 13.4109 mL | |
| 10 mM | 0.2682 mL | 1.3411 mL | 2.6822 mL | 6.7055 mL | |
| 15 mM | 0.1788 mL | 0.8941 mL | 1.7881 mL | 4.4703 mL | |
| 20 mM | 0.1341 mL | 0.6705 mL | 1.3411 mL | 3.3527 mL | |
| 25 mM | 0.1073 mL | 0.5364 mL | 1.0729 mL | 2.6822 mL | |
| 30 mM | 0.0894 mL | 0.4470 mL | 0.8941 mL | 2.2352 mL | |
| 40 mM | 0.0671 mL | 0.3353 mL | 0.6705 mL | 1.6764 mL | |
| 50 mM | 0.0536 mL | 0.2682 mL | 0.5364 mL | 1.3411 mL | |
| 60 mM | 0.0447 mL | 0.2235 mL | 0.4470 mL | 1.1176 mL | |
| 80 mM | 0.0335 mL | 0.1676 mL | 0.3353 mL | 0.8382 mL | |
| 100 mM | 0.0268 mL | 0.1341 mL | 0.2682 mL | 0.6705 mL |
DCH36_06 Related Classifications
HY-139108 Related Classifications
Powered by Bioz